Deutsche Bank sets Sarepta stock target at $136, cites risks
Deutsche Bank (ETR:DBKGn) initiated coverage of Sarepta Therapeutics (NASDAQ:SRPT), assigning a Hold rating to the ...
Deutsche Bank sets Xenon stock Buy rating, $67 price target
Deutsche Bank (ETR:DBKGn) initiated coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and a price target of ...
Deutsche Bank’s Heavier Costs Drag Shares Despite Investment Bank Strength
The lender’s better-than-expected performance in investment banking was overshadowed by a drop in profit and shares slumped ...
Deutsche Bank shares drop after quarterly profit falls, cost target scrapped
Legal provisions weighed on the bottom line at Germany’s largest lender Deutsche Bank, with net profit falling in the fourth ...
MarketWatch13d
Deutsche Bank is a victim of its own success as it hikes cost guidance
Deutsche Bank delivered bad news on spending, and investors weren’t happy. Deutsche Bank on Thursday said it’s now targeting a cost-to-income ratio of below 65% this year, versus a previous ...
MarketWatch1mon
Deutsche Bank says it’s now overweight Europe stocks vs. the U.S. Valuation is just one reason.
There’s never been a bigger valuation gap between European and U.S. stocks, and that’s not the only reason why Deutsche Bank now says it prefers equities on the Continent on a tactical basis.
Seeking Alpha1mon
Deutsche Bank said to plan 10% boost to investment bank bonuses
Deutsche Bank (NYSE:DB) is planning a roughly 10% increase in bonuses for its investment bankers, aligning their compensation with that of other major Wall Street firms, according to a media ...